C. Koenecke Et Al. , "Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party," BONE MARROW TRANSPLANTATION , vol.51, no.9, pp.1259-1261, 2016
Koenecke, C. Et Al. 2016. Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party. BONE MARROW TRANSPLANTATION , vol.51, no.9 , 1259-1261.
Koenecke, C., Heim, D., van Biezen, A., Heuser, M., Aljurf, M., Kyrcz-Krzemien, S., ... Volin, L.(2016). Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party. BONE MARROW TRANSPLANTATION , vol.51, no.9, 1259-1261.
Koenecke, C. Et Al. "Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party," BONE MARROW TRANSPLANTATION , vol.51, no.9, 1259-1261, 2016
Koenecke, C. Et Al. "Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party." BONE MARROW TRANSPLANTATION , vol.51, no.9, pp.1259-1261, 2016
Koenecke, C. Et Al. (2016) . "Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party." BONE MARROW TRANSPLANTATION , vol.51, no.9, pp.1259-1261.
@article{article, author={C. Koenecke Et Al. }, title={Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party}, journal={BONE MARROW TRANSPLANTATION}, year=2016, pages={1259-1261} }